ES2125248T3 - Metodo de deteccion de una infeccion cmv. - Google Patents

Metodo de deteccion de una infeccion cmv.

Info

Publication number
ES2125248T3
ES2125248T3 ES92303259T ES92303259T ES2125248T3 ES 2125248 T3 ES2125248 T3 ES 2125248T3 ES 92303259 T ES92303259 T ES 92303259T ES 92303259 T ES92303259 T ES 92303259T ES 2125248 T3 ES2125248 T3 ES 2125248T3
Authority
ES
Spain
Prior art keywords
cmv infection
detection method
cd45ra
ratio
cd45ro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92303259T
Other languages
English (en)
Inventor
Thomas Totterman
Erland Hanas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2125248T3 publication Critical patent/ES2125248T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO Y EQUIPO PARA LA PREDICCION Y DETECCION DE INFECCION DE CMV EN PACIENTES CON ORGANO TRASPLANTADO. EL METODO COMPRENDE EL USO DE ANTICUERPOS NONOCLONALES FLUORESCENTEMENTE MARCADOS CONTRA LOS ANTIGENOS CD45RO, CD45RA Y CD4 SOBRE UNA MUESTRA DE SANGRE Y QUE DETERMINA LA PROPORCION DE CD45RA:CD45RO SOBRE CELULAS T DE CD4+. UNA PROPORCION MAYOR QUE 1 SE CORRELACIONA CON LA INFECCION DE CMV.
ES92303259T 1992-04-10 1992-04-10 Metodo de deteccion de una infeccion cmv. Expired - Lifetime ES2125248T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92303259A EP0564735B1 (en) 1992-04-10 1992-04-10 Method for detection of CMV infection

Publications (1)

Publication Number Publication Date
ES2125248T3 true ES2125248T3 (es) 1999-03-01

Family

ID=8211327

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92303259T Expired - Lifetime ES2125248T3 (es) 1992-04-10 1992-04-10 Metodo de deteccion de una infeccion cmv.

Country Status (4)

Country Link
EP (1) EP0564735B1 (es)
AT (1) ATE173543T1 (es)
DE (1) DE69227623T2 (es)
ES (1) ES2125248T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010542A1 (fr) * 2001-07-25 2003-02-06 Mitsubishi Pharma Corporation Diagnostics du cancer
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
ES2654543T3 (es) 2008-07-16 2018-02-14 Institute For Research In Biomedicine Anticuerpos neutralizantes del citomegalovirus humano y uso de los mismos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745285A (en) * 1986-08-21 1988-05-17 Becton Dickinson And Company Multi-color fluorescence analysis with single wavelength excitation
FI105320B (fi) * 1988-04-04 2000-07-31 Oncogen Menetelmä vasta-aineheterokonjugaattien valmistamiseksi, joita käytetään imusoluaktiivisuuden säätelyssä ja diagnoosissa

Also Published As

Publication number Publication date
EP0564735A1 (en) 1993-10-13
DE69227623T2 (de) 1999-05-20
DE69227623D1 (de) 1998-12-24
ATE173543T1 (de) 1998-12-15
EP0564735B1 (en) 1998-11-18

Similar Documents

Publication Publication Date Title
CA2224003A1 (en) Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
NO169243C (no) Monoklonalt antistoff, hybridcellelinje og anvendelse av det monoklonale antistoffet for analyse av leukocytt-populasjonen i en proeve av humant perifert blod
SE9600949D0 (sv) Method of diagnosing a mycobacterial disease and immunoassay kit
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
ES2125248T3 (es) Metodo de deteccion de una infeccion cmv.
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
CA2078651A1 (en) Wash composition, test kit and method for determination of microorganisms associated with periodontal diseases
FI922666A0 (fi) Diagnostiskt foerfarande.
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
DE3587542D1 (de) Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren.
FI973418A0 (fi) Vasta-ainetuotannon toteaminen
ATE76974T1 (de) Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
ES2033834T3 (es) Un metodo para determinar alteraciones de la gestion.
IE882250L (en) Monoclonal antibodies and methods for diagnosis of Phytophthora infection
WO1990008956A1 (fr) Detection d'activateur de facteur tissulaire humain
DE3863270D1 (de) Immuntest.
Cartun et al. Immunoperoxidase Localization of Pneumocystis carinii in Formalin Fixed, Paraffin Embedded Tissue with Monoclonal Antibody 2G2
DK0556281T3 (da) Diagnoseassay for Lyme sygdom
RU93015117A (ru) Способ определения "группы риска" рецидива лепры
IT1226700B (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
RU94043032A (ru) Способ индикации бактериальных антигенов
SE8901988D0 (sv) Saett att diagnostisera in vitro en aktiv infektionfoerorsakad av en mikroorganism

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 564735

Country of ref document: ES